Skip to main content
. 2017 Feb 9;79(3):507–518. doi: 10.1007/s00280-017-3240-x

Fig. 2.

Fig. 2

Mean plasma concentration–time profiles of TRA, ponatinib, and metabolites M14 (AP24600), M23 (AP32318), and M42 (AP24567). Error bars represent SD; n = 6. TRA in plasma was determined using liquid scintillation counting. Ponatinib and its metabolites (M14 and M42) were quantitated using LC/MS/MS methods, whereas M23 was quantitated by radiochromatography [M23 (nM) = ponatinib concentration (nM) × radioactivity ratio of M23/ponatinib]. LC/MS/MS liquid chromatography with tandem mass spectrometry. SD standard deviation, TRA total radioactivity